Short Interest Buzzer: What’s Next for Surgery Partners Incorporated (NASDAQ:SGRY) After Having Less Shares Shorted?

November 15, 2016 - By Peter Erickson   ·   0 Comments

Short Interest Buzzer: What's Next for Surgery Partners Incorporated (NASDAQ:SGRY) After Having Less Shares Shorted?

The stock of Surgery Partners Incorporated (NASDAQ:SGRY) registered a decrease of 8.08% in short interest. SGRY’s total short interest was 1.08M shares in November as published by FINRA. Its down 8.08% from 1.17 million shares, reported previously. With 198,900 shares average volume, it will take short sellers 5 days to cover their SGRY’s short positions. The short interest to Surgery Partners Incorporated’s float is 5.84%. About 145,856 shares traded hands. Surgery Partners Inc (NASDAQ:SGRY) has risen 20.29% since April 13, 2016 and is uptrending. It has outperformed by 16.36% the S&P500.

Surgery Partners, Inc. is a healthcare services company. The company has a market cap of $786.66 million. The Firm operates in three lines of business across the United States: Surgical Facility Services, Ancillary Services and Optical Services. It has a 99.14 P/E ratio. The Company’s Surgical Facility Services segment consists of the operation of ambulatory surgery centers and surgical hospitals, which include its anesthesia services.

Surgery Partners Inc (NASDAQ:SGRY) Ratings Coverage

Out of 9 analysts covering Surgery Partners (NASDAQ:SGRY), 7 rate it a “Buy”, 0 “Sell”, while 2 “Hold”. This means 78% are positive. Surgery Partners has been the topic of 10 analyst reports since October 26, 2015 according to StockzIntelligence Inc. The stock of Surgery Partners Inc (NASDAQ:SGRY) has “Overweight” rating given on Friday, June 10 by KeyBanc Capital Markets. The firm has “Buy” rating given on Monday, October 26 by Jefferies. The stock has “Outperform” rating given by RBC Capital Markets on Monday, October 26. Morgan Stanley initiated Surgery Partners Inc (NASDAQ:SGRY) on Monday, October 26 with “Equal-Weight” rating. The stock has “Buy” rating given by Stifel Nicolaus on Tuesday, October 27. The rating was initiated by Goldman Sachs with “Neutral” on Monday, October 26. Citigroup initiated the stock with “Buy” rating in Monday, October 26 report. The stock of Surgery Partners Inc (NASDAQ:SGRY) earned “Strong Buy” rating by Raymond James on Monday, October 26. The rating was maintained by Citigroup on Monday, March 14 with “Buy”. The stock of Surgery Partners Inc (NASDAQ:SGRY) has “Buy” rating given on Monday, October 26 by Bank of America.

SGRY Company Profile

Surgery Partners, Inc., incorporated on April 2, 2015, is a healthcare services company. The Firm operates in three lines of business across the United States: Surgical Facility Services, Ancillary Services and Optical Services. The Company’s Surgical Facility Services segment consists of the operation of ambulatory surgery centers (ASCs) and surgical hospitals, which include its anesthesia services.

More notable recent Surgery Partners Inc (NASDAQ:SGRY) news were published by: Marketwatch.com which released: “Surgery Partners started at strong buy with $25 stock price target at Raymond …” on August 21, 2015, also Finance.Yahoo.com with their article: “Surgery Partners, Inc. Announces Third Quarter 2016 Earnings Release Date and …” published on October 20, 2016, Globenewswire.com published: “Surgery Partners, Inc. Appoints Teresa DeLuca, M.D. to the Board of Directors” on September 30, 2016. More interesting news about Surgery Partners Inc (NASDAQ:SGRY) were released by: Quotes.Wsj.com and their article: “News Surgery Partners Inc.SGRY” published on September 26, 2015 as well as Globenewswire.com‘s news article titled: “Surgery Partners, Inc. Announces Second Quarter 2016 Earnings Release Date and …” with publication date: July 21, 2016.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By Peter Erickson


Readers Comments (0)





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Market News

>